Affiliate link — we may earn a commission at no extra cost to you.
This product has come up 3 times across 2 different shows: Andrew Huberman, Tim Ferriss. 3 of those mentions were genuine on-air recommendations, not just passing references. The people who brought it up: Matt Kaeberlein, Peter Attia. The earliest mention we indexed is from 2021-06-09 and the most recent from 2022-08-15. Every occurrence below links to the episode page and to the exact second it was said on YouTube.
“let's use rapamycin as an example, right? I'm a huge proponent of rapamycin.”— Peter Attia
The guest here is Dr. Peter Attia: Stanford-trained physician (MD) and Johns Hopkins-trained surgeon focused on longevity, who runs a clinical practice optimizing lifespan and health span and hosts the podcast The Drive. Peter Attia gives Andrew Huberman a clinic-grade masterclass on the blood markers, exercise, and hormones that actually extend lifespan and health span.
“that's the drug that i if i had to pick one intervention that's the one that i have focused on the most throughout my career”— Matt Kaeberlein
The guest here is Dr. Matt Kaeberlein: Professor of laboratory medicine and pathology at the University of Washington School of Medicine, founding director of the UW Healthy Aging and Longevity Research Institute, and founder/co-director of the Dog Aging Project; a leading researcher on the biology of aging and rapamycin. Aging biologist Matt Kaeberlein on rapamycin, why most longevity hype (resveratrol, sirtuins, NAD) fails the data, and healthspan over lifespan.
“i'm more bullish on rappa simply because i'm you know i've been taking it now for three years”— Peter Attia
The guest here is Dr. Peter Attia: A physician focused on the applied science of longevity, blending nutrition, exercise, sleep, and pharmacology to extend lifespan and healthspan. A former ultra-endurance athlete and host of The Drive podcast, he trained at Johns Hopkins and NIH and holds an MD from Stanford. Peter Attia and Tim Ferriss go deep on longevity drugs, cancer screening, zone two training, psilocybin research, and how to read studies.